SNV1521

DRUG2 trials

Sponsors

Synnovation Therapeutics, Inc.

Conditions

Advanced Solid TumorPancreatic Acinar CarcinomaPancreatic Cancer

Phase 1

SNV1521 in Participants With Advanced Solid Tumors

RecruitingNCT06220864

Synnovation Therapeutics, Inc.Advanced Solid Tumor

Start: 2024-02-23End: 2027-12-01Target: 400Updated: 2026-06-25

First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer

Not yet recruitingNCT07756281

Synnovation Therapeutics, Inc.Pancreatic Cancer, Pancreatic Acinar Carcinoma

Start: 2026-09-01End: 2029-06-01Target: 40Updated: 2026-08-10